- Previous Close
2.9300 - Open
3.1800 - Bid 3.0500 x 40000
- Ask 3.0600 x 40000
- Day's Range
2.9300 - 3.1800 - 52 Week Range
2.4500 - 5.1200 - Volume
1,250 - Avg. Volume
28,581 - Market Cap (intraday)
755.357M - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
13.79 - EPS (TTM)
0.2200 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada.
well.company--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WHTCF
View MorePerformance Overview: WHTCF
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WHTCF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WHTCF
View MoreValuation Measures
Market Cap
753.27M
Enterprise Value
984.02M
Trailing P/E
13.99
Forward P/E
13.79
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.14
Price/Book (mrq)
1.28
Enterprise Value/Revenue
1.47
Enterprise Value/EBITDA
7.12
Financial Highlights
Profitability and Income Statement
Profit Margin
7.67%
Return on Assets (ttm)
2.45%
Return on Equity (ttm)
10.89%
Revenue (ttm)
957.69M
Net Income Avi to Common (ttm)
73.42M
Diluted EPS (ttm)
0.2200
Balance Sheet and Cash Flow
Total Cash (mrq)
66.15M
Total Debt/Equity (mrq)
43.18%
Levered Free Cash Flow (ttm)
122.67M